首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1638824

注射器市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Syringes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月04日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球注射器市場估值為196 億美元，預計2024 年至2032 年複合年成長率為10.9%。的針頭或噴嘴組成控制。

該市場的成長是由人口老化和慢性健康狀況的增加所推動的，這增加了對安全、可靠的注射設備的需求。此外，隨著患者在臨床環境之外尋求更方便、更實惠的治療解決方案，家庭醫療保健採用的增加支持注射器的使用。

市場按製劑分為即用型 (RTU) 和即用型 (RTS) 注射器。 RTU 領域引領市場，預計複合年成長率為 11.1%，因為它為醫療保健提供者和患者提供了便利。 RTU 注射器通常預先填充藥物，可簡化給藥、最大限度地減少劑量錯誤並降低污染風險。它們的設計提高了依從性，特別是在慢性病管理方面，並且由於易於自我管理而越來越受到家庭醫療保健的青睞。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	196 億美元
預測值	491 億美元
複合年成長率	10.9%

按應用分類，市場分為小分子、診斷和生物製劑，到2023年，生物製劑將佔據54.7%的佔有率。需求，這些藥物需要精確的遞送方法。向個人化醫療的轉變進一步強調了對高效輸送系統的需求，從而鞏固了生物製劑的市場主導地位。

在北美，受先進的醫療基礎設施、強大的研發力度和對醫療設備的高需求的推動，美國以 10.6% 的複合年成長率領先。美國對創新的重視催生了先進的注射器技術，包括安全設計和預填充選項，可提高病患安全和治療效果。慢性病的增加和疫苗接種措施進一步刺激了市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病和老年人口增加
  - 加強疫苗接種力度
  - 關注病人安全的技術進步不斷進步
  - 生物製劑和生物相似藥研究活動的增加
- 產業陷阱與挑戰
  - 針刺傷的風險很高
  - 嚴格的監管要求
成長潛力分析
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按準備情況，2021 - 2032 年

主要趨勢
即用型 (RTU)
準備滅菌 (RTS)

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
小分子
生物製劑
診斷

第 7 章：市場估計與預測：按材料分類，2021 - 2032 年

主要趨勢
玻璃
塑膠/聚合物

第 8 章：市場估計與預測：按規模，2021 - 2032

主要趨勢
<1毫升
1毫升 - 2毫升
3毫升 - 5毫升
6 毫升 - 10 毫升
10 - 20 毫升
20 - 30 毫升
>30 毫升

第 9 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
醫院和診所
製藥和生物技術公司
合約開發與製造組織 (CDMO)
診斷實驗室
其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 11 章：公司簡介

Becton, Dickinson and Company (BD)
Cardinal Health
Corning
Daikyo Seiko
DWK Life Sciences
Gerresheimer AG
ICU Medical
Mitsubishi Gas Chemical Company
Nipro
SCHOTT Pharma (SCHOTT Group)
Shandong Province Medicinal Glass
SHIOTANI GLASS
Terumo
Weigao Group
West Pharmaceutical Services

簡介目錄

Product Code: 12084

The Global Syringes Market was valued at USD 19.6 billion in 2023, with projections indicating a 10.9% CAGR from 2024 to 2032. Syringes, vital medical devices for fluid injection and withdrawal, consist of a barrel, plunger, and needle or nozzle for precise fluid control.

Growth in this market is driven by an aging population and an increase in chronic health conditions, which elevate the demand for safe, reliable injection devices. Additionally, the rise in home healthcare adoption supports syringe use as patients seek more convenient and affordable treatment solutions beyond clinical settings.

The market is segmented by preparation into ready-to-use (RTU) and ready-to-sterilize (RTS) syringes. The RTU segment leads the market, with an anticipated 11.1% CAGR, owing to its convenience for healthcare providers and patients. Often prefilled with medication, RTU syringes simplify administration, minimize dosage errors, and reduce contamination risk. Their design promotes compliance, particularly in chronic disease management, and is increasingly favored in home healthcare due to the ease of self-administration.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$19.6 Billion
Forecast Value	$49.1 Billion
CAGR	10.9%

By application, the market is categorized into small molecules, diagnostics, and biologics, with biologics holding a 54.7% share in 2023. This segment's strength stems from the growing demand for biologic drugs targeting chronic and autoimmune conditions, which require precise delivery methods. The shift toward personalized medicine further underscores the need for efficient delivery systems, solidifying biologics' market dominance.

In North America, the U.S. leads with a CAGR of 10.6%, driven by advanced healthcare infrastructure, strong R&D efforts, and high demand for medical devices. The U.S. focus on innovation has produced advanced syringe technologies, including safety-engineered and prefilled options that enhance patient safety and treatment effectiveness. Rising chronic diseases and vaccination initiatives further stimulate market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising chronic diseases and geriatric population
  - 3.2.1.2 Increasing vaccination initiatives
  - 3.2.1.3 Growing technology advancement focusing on patient safety
  - 3.2.1.4 Rise in biologics and biosimilars research activities
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High risk of needlestick injuries
  - 3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)

5.1 Key trends
5.2 Ready to use (RTU)
5.3 Ready to sterilize (RTS)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)

6.1 Key trends
6.2 Small molecules
6.3 Biologics
6.4 Diagnostics

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)

7.1 Key trends
7.2 Glass
7.3 Plastic/ polymers

Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)

8.1 Key trends
8.2 <1 ml
8.3 1 ml - 2 ml
8.4 3 ml - 5 ml
8.5 6 ml - 10 ml
8.6 10 - 20 ml
8.7 20 - 30 ml
8.8 >30 ml

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

9.1 Key trends
9.2 Hospitals & clinics
9.3 Pharma & biotech companies
9.4 Contract development and manufacturing organizations (CDMOs)
9.5 Diagnostic laboratories
9.6 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Italy
- 10.3.5 Spain
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE